Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Revvity (DE:PKN)
FRANKFURT:PKN
Holding DE:PKN?
Track your performance easily
PKN Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€91.82 - €117.55
Previous Close€109.45
Volume0.00
Average Volume (3M)85.00
Market Cap
€13.42B
Enterprise Value€15.39B
Total Cash (Recent Filing)$1.23B
Total Debt (Recent Filing)$3.32B
Price to Earnings (P/E)44.5
Beta0.42
Next Earnings
Jan 29, 2025EPS Estimate
€1.3Next Dividend Ex-Date
Jan 17, 2025Dividend Yield0.24%
Share Statistics
EPS (TTM)2.46
Shares Outstanding121,702,145
10 Day Avg. Volume0
30 Day Avg. Volume85
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)1.68
Price to Sales (P/S)5.18
Price to Cash Flow (P/CF)23.90
P/FCF Ratio28.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.66
Enterprise Value/Gross Profit10.00
Enterprise Value/Ebitda25.35
Forecast
1Y Price Target
€126.14Price Target Upside15.25% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
Revvity News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceRVTY's transformed portfolio of select LST assets and its attractive ~80% recurring revenue profile drives its top-quartile margin (60%+ gross margins and ~30% operating margins) and is poised to generate strong incremental leverage when volumes recover.
Growth OpportunitiesReagents are set to drive new Life Science Solutions segment growth, with expansion into downstream GMP highlighted as a key growth opportunity.
Market StabilityThe diagnostics portfolio offers insulation from industry volatility, with continued strength in margins and a new $1B share repurchase authorization supporting market stability.
Bears Say
Financial PerformanceInstrumentation drove the majority of the quarter weakness and the guide cut for the full year.
Market ConditionsCustomer spending on instruments remains constrained, particularly in China.
Revenue GuidanceRVTY attributed the 2024 revenue guidance reduction to lowered expectations for overall instrumentation in 4Q.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.36% Insiders
35.13% Mutual Funds
31.82% Other Institutional Investors
9.31% Public Companies and
Individual Investors
PKN FAQ
What was Revvity’s price range in the past 12 months?
Revvity lowest stock price was €91.82 and its highest was €117.55 in the past 12 months.
What is Revvity’s market cap?
Currently, no data Available
When is Revvity’s upcoming earnings report date?
Revvity’s upcoming earnings report date is Jan 29, 2025 which is in 27 days.
How were Revvity’s earnings last quarter?
Revvity released its earnings results on Nov 04, 2024. The company reported €1.213 earnings per share for the quarter, beating the consensus estimate of €1.067 by €0.146.
Is Revvity overvalued?
According to Wall Street analysts Revvity’s price is currently Undervalued.
Does Revvity pay dividends?
Revvity pays a Quarterly dividend of €0.066 which represents an annual dividend yield of 0.24%. See more information on Revvity dividends here
What is Revvity’s EPS estimate?
Revvity’s EPS estimate is €1.3.
How many shares outstanding does Revvity have?
Revvity has 121,702,150 shares outstanding.
What happened to Revvity’s price movement after its last earnings report?
Revvity reported an EPS of €1.213 in its last earnings report, beating expectations of €1.067. Following the earnings report the stock price went up 4.587%.
Which hedge fund is a major shareholder of Revvity?
Among the largest hedge funds holding Revvity’s share is EdgePoint Investment Group Inc.. It holds Revvity’s shares valued at 343M.
---
Revvity Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€126.14 (15.25% Upside)
€126.14 (15.25% Upside)
Blogger Sentiment
Bullish
DE:PKN Sentiment 100%
Sector Average 70%
Sector Average 70%
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.79%
12-Months-Change
Fundamentals
Return on Equity
3.31%
Trailing 12-Months
Asset Growth
-4.86%
Trailing 12-Months
Company Description
Revvity
PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.
---
PKN Company Deck
---
PKN Earnings Call
Q3 2024
0:00 / 0:00
---
PKN Revenue Breakdown
53.02% Diagnostics
46.98% Life sciences
---
PKN Stock 12 Month Forecast
Average Price Target
€126.14
▲(15.25% Upside)
Technical Analysis
Best Analysts Covering PKN
1 Year
1 Year Success Rate
19/31 ratings generated profit
1 Year Average Return
+9.44%
reiterated a buy rating 2 months ago
Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 61.29% of your transactions generating a profit, with an average return of +9.44% per trade.
---